SUMO-1 interacts with mutant ataxin-1 and colocalizes to its aggregates in purkinje cells of SCA1 transgenic mice

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Spinocerebellar ataxia type 1 (SCA1) is one of several progressive neurodegenerative diseases caused by the expanded polyglutamine tract in ataxin-1, the SCA1 gene product. In SCA1 patients and transgenic mice, the affected neuronal cells contain a large ubiquitin-positive aggregate which is derived from the mutant ataxin-1. Small ubiquitin-like modifier-1 (SUMO-1) is one of the most intriguing ubiquitin-like modifiers being conjugated to target proteins and modulating a number of cellular pathways. Recent findings that the aggregates from several neurodegenerative diseases are SUMO-1-positive prompted us to examine the implication of SUMO-1 in SCA1 pathogenesis. In our yeast two-hybrid experiments using mutant ataxin-1 as bait, we identified a SUMO-1 protein that directly binds to ataxin-1 protein. Interestingly, we found that most of the mutant ataxin-1-derived aggregates were SUMO-1-positive both in Purkinje cells of SCA1 transgenic mice and in HeLa cells, but not wild-type ataxin-1 in HeLa cells. In addition, the aggregates in Purkinje cells of SCA1 transgenic mice were positive against both anti-SUMO-1 and anti-ubiquitin antibodies. These results show that the SUMO-1 protein interacts with mutant ataxin-1 and colocalizes with its aggregates which suggests the involvement of the SUMO-1 system in the pathogenesis of SCA1 disease.

Original languageEnglish
Pages (from-to)351-363
Number of pages13
JournalArchives Italiennes de Biologie
Volume148
Issue number4
Publication statusPublished - 2010 Dec 1

Fingerprint

Spinocerebellar Ataxias
Purkinje Cells
Ubiquitin
Transgenic Mice
HeLa Cells
Neurodegenerative Diseases
Ataxin-1
Proteins
Anti-Idiotypic Antibodies
Yeasts

Keywords

  • Aggregates
  • Mutant ataxin-1
  • Polyglutamine
  • SCA1
  • SUMO-1

ASJC Scopus subject areas

  • Medicine(all)
  • Cell Biology
  • Physiology

Cite this

@article{015fc9119fb64454a9baf06d155bbd9f,
title = "SUMO-1 interacts with mutant ataxin-1 and colocalizes to its aggregates in purkinje cells of SCA1 transgenic mice",
abstract = "Spinocerebellar ataxia type 1 (SCA1) is one of several progressive neurodegenerative diseases caused by the expanded polyglutamine tract in ataxin-1, the SCA1 gene product. In SCA1 patients and transgenic mice, the affected neuronal cells contain a large ubiquitin-positive aggregate which is derived from the mutant ataxin-1. Small ubiquitin-like modifier-1 (SUMO-1) is one of the most intriguing ubiquitin-like modifiers being conjugated to target proteins and modulating a number of cellular pathways. Recent findings that the aggregates from several neurodegenerative diseases are SUMO-1-positive prompted us to examine the implication of SUMO-1 in SCA1 pathogenesis. In our yeast two-hybrid experiments using mutant ataxin-1 as bait, we identified a SUMO-1 protein that directly binds to ataxin-1 protein. Interestingly, we found that most of the mutant ataxin-1-derived aggregates were SUMO-1-positive both in Purkinje cells of SCA1 transgenic mice and in HeLa cells, but not wild-type ataxin-1 in HeLa cells. In addition, the aggregates in Purkinje cells of SCA1 transgenic mice were positive against both anti-SUMO-1 and anti-ubiquitin antibodies. These results show that the SUMO-1 protein interacts with mutant ataxin-1 and colocalizes with its aggregates which suggests the involvement of the SUMO-1 system in the pathogenesis of SCA1 disease.",
keywords = "Aggregates, Mutant ataxin-1, Polyglutamine, SCA1, SUMO-1",
author = "Kang, {Seong Man} and Sunghoi Hong",
year = "2010",
month = "12",
day = "1",
language = "English",
volume = "148",
pages = "351--363",
journal = "Archives Italiennes de Biologie",
issn = "0003-9829",
publisher = "Pisa University Press",
number = "4",

}

TY - JOUR

T1 - SUMO-1 interacts with mutant ataxin-1 and colocalizes to its aggregates in purkinje cells of SCA1 transgenic mice

AU - Kang, Seong Man

AU - Hong, Sunghoi

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Spinocerebellar ataxia type 1 (SCA1) is one of several progressive neurodegenerative diseases caused by the expanded polyglutamine tract in ataxin-1, the SCA1 gene product. In SCA1 patients and transgenic mice, the affected neuronal cells contain a large ubiquitin-positive aggregate which is derived from the mutant ataxin-1. Small ubiquitin-like modifier-1 (SUMO-1) is one of the most intriguing ubiquitin-like modifiers being conjugated to target proteins and modulating a number of cellular pathways. Recent findings that the aggregates from several neurodegenerative diseases are SUMO-1-positive prompted us to examine the implication of SUMO-1 in SCA1 pathogenesis. In our yeast two-hybrid experiments using mutant ataxin-1 as bait, we identified a SUMO-1 protein that directly binds to ataxin-1 protein. Interestingly, we found that most of the mutant ataxin-1-derived aggregates were SUMO-1-positive both in Purkinje cells of SCA1 transgenic mice and in HeLa cells, but not wild-type ataxin-1 in HeLa cells. In addition, the aggregates in Purkinje cells of SCA1 transgenic mice were positive against both anti-SUMO-1 and anti-ubiquitin antibodies. These results show that the SUMO-1 protein interacts with mutant ataxin-1 and colocalizes with its aggregates which suggests the involvement of the SUMO-1 system in the pathogenesis of SCA1 disease.

AB - Spinocerebellar ataxia type 1 (SCA1) is one of several progressive neurodegenerative diseases caused by the expanded polyglutamine tract in ataxin-1, the SCA1 gene product. In SCA1 patients and transgenic mice, the affected neuronal cells contain a large ubiquitin-positive aggregate which is derived from the mutant ataxin-1. Small ubiquitin-like modifier-1 (SUMO-1) is one of the most intriguing ubiquitin-like modifiers being conjugated to target proteins and modulating a number of cellular pathways. Recent findings that the aggregates from several neurodegenerative diseases are SUMO-1-positive prompted us to examine the implication of SUMO-1 in SCA1 pathogenesis. In our yeast two-hybrid experiments using mutant ataxin-1 as bait, we identified a SUMO-1 protein that directly binds to ataxin-1 protein. Interestingly, we found that most of the mutant ataxin-1-derived aggregates were SUMO-1-positive both in Purkinje cells of SCA1 transgenic mice and in HeLa cells, but not wild-type ataxin-1 in HeLa cells. In addition, the aggregates in Purkinje cells of SCA1 transgenic mice were positive against both anti-SUMO-1 and anti-ubiquitin antibodies. These results show that the SUMO-1 protein interacts with mutant ataxin-1 and colocalizes with its aggregates which suggests the involvement of the SUMO-1 system in the pathogenesis of SCA1 disease.

KW - Aggregates

KW - Mutant ataxin-1

KW - Polyglutamine

KW - SCA1

KW - SUMO-1

UR - http://www.scopus.com/inward/record.url?scp=79551524400&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551524400&partnerID=8YFLogxK

M3 - Article

VL - 148

SP - 351

EP - 363

JO - Archives Italiennes de Biologie

JF - Archives Italiennes de Biologie

SN - 0003-9829

IS - 4

ER -